Back to CYTK

ARMISTICE CAPITAL, LLC → CYTK

ARMISTICE CAPITAL, LLC CYTK Position History

Cytokinetics, Incorporated • Healthcare

Quarters held
15
Latest value
$63.3M
Q3 2026
Peak value
$106.5M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$52.2M
Q3 2025$65.8M
Q4 2025$63.1M
Q4 2025$63.5M
Q4 2025$31.8M
Q1 2026$50.4M
Q1 2026$56M
Q1 2026$56M
Q1 2026$13.2M
Q2 2026$102.3M
Q2 2026$106.5M
Q2 2026$23.9M
Q3 2026$77.8M
Q3 2026$105.5M
Q3 2026$63.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$63.3M960.0K——
Q3 2026$105.5M1.60M——
Q3 2026$77.8M1.18M——
Q2 2026$23.9M280.0K——
Q2 2026$106.5M1.25M——
Q2 2026$102.3M1.20M——
Q1 2026$13.2M200.0K——
Q1 2026$56M850.0K——
Q1 2026$56M850.0K——
Q1 2026$50.4M764.5K——
Q4 2025$31.8M500.0K——
Q4 2025$63.5M1.00M——
Q4 2025$63.1M992.8K——
Q3 2025$65.8M1.20M——
Q3 2025$52.2M950.0K——

Other funds holding CYTK

Other ARMISTICE CAPITAL, LLC positions

PTCT

PTC THERAPEUTICS INC

$212.8M
PTCT

PTC THERAPEUTICS ORD

$201.1M
TVTX

TRAVERE THERAPEUTICS ORD

$160.7M
IMVT

IMMUNOVANT INC

$146.1M
TVTX

TRAVERE THERAPEUTICS INC

$145.5M
TVTX

TRAVERE THERAPEUTICS INC

$143.8M
PTCT

PTC THERAPEUTICS INC

$141.3M
SUPN

SUPERNUS PHARMACEUTICALS INC

$137.4M